文献速递肺外科心外重症与机械循环支持

机械通气与体外膜氧合作为肺移植桥接:差距缩小

Mechanical ventilation and extracorporeal membrane oxygenation as a bridge to lung transplantation: Closing the gap.
PubMed 文献 · J Heart Lung Transplant · 2019-07-04

该研究基于美国器官共享联合网络数据库2005-2017年数据,分析21,576例肺移植受者,比较无桥接、机械通气(MV)和体外膜氧合(ECMO)桥接者的结局与生存。结果显示ECMO桥接使用显著增加(后期1% vs 5%,p<0.001),MV和ECMO组5年死亡风险均高于无桥接组,但MV与ECMO组间无差异(HR 0.98,p=0.817),且ECMO组死亡率在后期下降(HR 0.54,p=0.006)。

要点

  • ECMO桥接肺移植使用率十年间增加271%,MV桥接减少38%。
  • MV和ECMO桥接者5年死亡风险均高于无桥接者,但两者间无差异。
  • ECMO桥接者死亡率在后期(2012-2017)显著改善(HR 0.54,p=0.006)。

核心结论

  • ECMO作为肺移植桥接的使用增加271%,MV减少38%,ECMO生存显著改善且与MV桥接相当。

研究设计与样本

  • 回顾性队列研究,分析美国器官共享联合网络数据库2005-2017年21,576例肺移植受者,按桥接方式分无桥接(n=19,783)、MV(n=1,129)和ECMO(n=664)三组,多变量回归分析调整临床特征、时代和中心容量。

主要发现

  • ECMO使用在后期(2012-2017)显著增加(1% vs 5%,p<0.001)。
  • 与无桥接相比,MV和ECMO组围术期结局(通气>48小时、急性排斥、透析)风险更高。
  • MV组相比ECMO组,通气>48小时(p=0.003)、透析(p=0.003)、术后ECMO(p=0.006)风险更低,再插管风险更高(p=0.005)。
  • MV组(HR 1.45,p<0.001)和ECMO组(HR 1.48,p<0.001)5年死亡风险均高于无桥接组,但两组间无差异(HR 0.98,p=0.817)。
  • ECMO组死亡率在后期下降(HR 0.54,p=0.006)。

临床怎么用

  • ECMO可作为肺移植桥接的有效选择,尤其在后期的应用中生存已与MV桥接相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to examine outcomes and survival with mechanical ventilation (MV) and extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation (LT) using a national registry. METHODS: The United Network for Organ Sharing database was analyzed for recipients in the period 2005 to 2017. Recipients were categorized into 3 groups based on pre-transplant bridging. Multivariable regression analyses examined the effect of bridging on post-LT outcomes adjusting for clinical characteristics, including era (early = 2005-2011, late = 2012-2017) and center volume. RESULTS: There were 21,576 LT recipients: no bridge (n = 19,783), MV (n = 1,129), and ECMO (n = 664). Mean age was 54 ± 15 years (41% female). Use of ECMO increased significantly in the late era (1% vs 5%, p < 0.001). Compared with no bridge, patients with MV and ECMO had greater odds for peri-operative outcomes including ventilator support >48 hours, acute rejection, and dialysis. Patients with MV had reduced odds for ventilator support >48 hours (p = 0.003), dialysis (p = 0.003), post-operative ECMO (p = 0.006), and greater odds for reintubation (p = 0.005) compared with ECMO. Patients in both MV (hazard raio [HR] 1.45, p < 0.001) and ECMO (HR 1.48, p < 0.001) groups had greater risk for 5-year mortality, but MV and ECMO groups did not differ (HR 0.98, p = 0.817). Risk for mortality in the ECMO group decreased in the later era (HR 0.54, p = 0.006). CONCLUSIONS: ECMO as a bridge to LT has increased 271%, while MV has decreased 38% over the past decade. Survival with ECMO has significantly improved and is now equivalent to survival in recipients bridged on MV. These results suggest gains in use, outcomes, and safety of ECMO in this patient cohort.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Hayanga JWA, Hayanga HK, Holmes SD, et al. Mechanical ventilation and extracorporeal membrane oxygenation as a bridge to lung transplantation: Closing the gap. J Heart Lung Transplant. 2019. PMID: 31443999. doi:10.1016/j.healun.2019.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。